Application of AOSpine Subaxial Cervical Spine Injury Classification in Simple and Complex Cases. PMID: 28816872
Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor. PMID: 7916899
LMP1 TRAFficking activates growth and survival pathways. PMID: 17633026
Epstein-Barr Virus LMP1 Modulates the CD63 Interactome. PMID: 33920772
EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis. PMID: 35846746
Epstein-Barr virus latency: current and future perspectives. PMID: 26453799
LMP1 structure and signal transduction. PMID: 11669605
Activation of MEK1/2/Nrf-2 Signaling Pathway by Epstein-Barr Virus-Latent Membrane Protein 1 Enhances Autophagy and Cisplatin Resistance in T-Cell Lymphoma. PMID: 34239803
Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based meta-analysis. PMID: 26336130
Ceramide-dependent trafficking of Epstein-Barr virus LMP1 to small extracellular vesicles. PMID: 36958217
The role of Epstein-Barr virus in epithelial malignancies. PMID: 25251730
[Mechanisms of EBV-mediated oncogenesis]. PMID: 17446669
Characterization of the rapamycin-inducible EBV LMP1 activation system. PMID: 26428925
Viruses and Hodgkin's disease. PMID: 8395622
[Molecular biological properties of the Epstein-Barr virus LMP1 gene: structure, function and polymorphism]. PMID: 26281300
Epstein-Barr Virus B Cell Growth Transformation: The Nuclear Events. PMID: 37112815
RPS27a enhances EBV-encoded LMP1-mediated proliferation and invasion by stabilizing of LMP1. PMID: 28735865
Epstein-Barr virus in Hodgkin's disease. PMID: 8946602
Transmembrane Domains Mediate Intra- and Extracellular Trafficking of Epstein-Barr Virus Latent Membrane Protein 1. PMID: 29950415
Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1. PMID: 28794023
Viral involvement in Hodgkin's disease. PMID: 1334112
The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). PMID: 22249143
Epstein-Barr virus (HHV-4) inoculation to rabbits by intranasal and oral routes results in subacute and/or persistent infection dissimilar to human disease. PMID: 24993954
Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells. PMID: 28179525
Epstein-Barr virus and gastric carcinoma. PMID: 8946601
()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes. PMID: 33629943
Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups. PMID: 29950426
LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis. PMID: 25485679
Epstein-Barr virus: exploiting the immune system. PMID: 11905817
Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1. PMID: 18713013
Epstein-Barr Virus LMP1 Promotes Syntenin-1- and Hrs-Induced Extracellular Vesicle Formation for Its Own Secretion To Increase Cell Proliferation and Migration. PMID: 32546618
Molecular Characterisation of Epstein-Barr Virus in Classical Hodgkin Lymphoma. PMID: 36555277
Epstein-Barr virus latent membrane protein 1: structure and functions. PMID: 12928589
Epstein-Barr virus (EBV)-associated lymphoid lesions of the head and neck. PMID: 25804341
Epstein-Barr virus: LMP1 masquerades as an active receptor. PMID: 9512412
LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1. PMID: 25948750
The LMP1 promoter can be transactivated directly by NF-kappaB. PMID: 19279104
Caspase-dependent cleavage regulates protein levels of Epstein-Barr virus-derived latent membrane protein 1. PMID: 26921582
LMP1 and LMP2A are potential prognostic markers of extranodal NK/T-cell lymphoma, nasal type (ENKTL). PMID: 23237707
Regulation of Latent Membrane Protein 1 Signaling through Interaction with Cytoskeletal Proteins. PMID: 25948738
Phage-display screening identifies LMP1-binding peptides targeting the C-terminus region of the EBV oncoprotein. PMID: 27650372
Bystander inhibition of humoral immune responses by Epstein-Barr virus LMP1. PMID: 30137504
Epstein-Barr Virus-Specific Humoral Immune Responses in Health and Disease. PMID: 26428379
Transcriptome changes induced by Epstein-Barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma. PMID: 22991431
Are particular Epstein-Barr virus strains linked to disease? PMID: 8946605
LMP1+SLAMF1high cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells. PMID: 28445949
Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal. PMID: 25879824
Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Types. PMID: 26424646
Epstein-Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b. PMID: 19966860
Restricted expression of EBV encoded proteins in in vitro infected CLL cells. PMID: 21034831
Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais. PMID: 18180201
Role of Epstein-Barr virus in Burkitt's lymphoma. PMID: 11443859
[Anti-apoptotic function of the Epstein-Barr virus LMP1 and BHRF1 proteins]. PMID: 8741677
Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia. PMID: 19429479
Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production. PMID: 15767441
Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response. PMID: 34728343
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas., PMID:39908567
EBV-induced upregulation of CD55 reduces the efficacy of cetuximab treatment in nasopharyngeal carcinoma., PMID:39695702
Differential EBV protein-specific antibody response between responders and non-responders to EBVSTs immunotherapy., PMID:39211169
A proteome-wide analysis unveils a core Epstein-Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations., PMID:38995124
Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma., PMID:38276183
Serum Anti-Zta and Anti-LMP1 Antibodies in Oropharyngeal Cancer Related to Epstein-Barr Virus-Diagnostic Usefulness., PMID:38254830
CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy., PMID:38211650
LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells., PMID:38169736
Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus., PMID:38146370
Understanding the role of membrane cholesterol upon Epstein Barr virus infection in astroglial cells., PMID:37876925
Molecular detection of Epstein-Barr virus among Sudanese patients diagnosed with Hashimoto's thyroiditis., PMID:37858193
Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein-Barr Virus LMP1 Protein., PMID:37512884
Vaccination against Epstein-Barr Latent Membrane Protein 1 Protects against an Epstein-Barr Virus-Associated B Cell Model of Lymphoma., PMID:37508413
Inhibitory NKG2A+ and absent activating NKG2C+ NK cell responses are associated with the development of EBV+ lymphomas., PMID:37426645
Novel Bifunctional Affibody Molecules with Specific Binding to Both EBV LMP1 and LMP2 for Targeted Therapy of Nasopharyngeal Carcinoma., PMID:37373272
Epstein-Barr virus in breast carcinoma and in triple negative cases impact on clinical outcomes., PMID:37116366
Epstein-Barr Virus-Positive Leiomyosarcoma in Immunocompetent Patients., PMID:36951222
Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus., PMID:36782252
Association of human papillomavirus and Epstein-Barr virus with squamous cell carcinoma of upper aerodigestive tract., PMID:36683943
PD-L1 and EBV LMP1 expressions in classic Hodgkin lymphomas and its correlation with clinicopathological parameters and prognosis., PMID:36326378
Incidence of Epstein-Barr Virus Among Women With Breast Cancer Using Monoclonal Antibodies for Latent Membrane Protein 1 (LMP1)., PMID:35478129
Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis., PMID:34790199
Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response., PMID:34728343
Uncovering early events in primary Epstein-Barr virus infection using a rabbit model., PMID:34707156
Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases., PMID:34691042
Plasmablastic lymphomas show restricted EBV latency profile and MYC gene aberrations., PMID:34612761
Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma., PMID:34546798
Updating targets for natural killer/T-cell lymphoma immunotherapy., PMID:33628584
Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity., PMID:33613527
Selection of new immunotherapy targets for NK/T cell lymphoma., PMID:33312349
A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma., PMID:33067267
Epstein-Barr virus infection in patients with chronic gastritis without Helicobacter pylori infection., PMID:32343232
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis., PMID:32333154
[Expression of LMP-1 protein in tumor cells and glandular epithelium of the peritumoral tissue in gastric cancer]., PMID:31851189
CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo., PMID:31807014
Construction of Epstein-Bar virus cocktail peptide fused with Fcγ of IgG: as a potential delivery system for vaccine development., PMID:31739735
Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma., PMID:31618442
Total Antioxidant Status (TAS), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) in Oropharyngeal Cancer Associated with EBV Infection., PMID:31360295
Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma., PMID:31063269
Fibronectin promotes nasopharyngeal cancer cell motility and proliferation., PMID:30551431
Epstein Barr Virus in Patients with Nephropathy Associated with Systemic Lupus Erythematous, Pilot Study in Egyptian Patients., PMID:30242993
Bystander inhibition of humoral immune responses by Epstein-Barr virus LMP1., PMID:30137504
Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas., PMID:29946193
Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma., PMID:29761078
The Relationship Between Environmental Factors and the Profile of Epstein-Barr Virus Antibodies in the Lytic and Latent Infection Periods in Healthy Populations from Endemic and Non-Endemic Nasopharyngeal Carcinoma Areas in China., PMID:29606628
The Possible Effect of B-Cell Epitopes of Epstein-Barr Virus Early Antigen, Membrane Antigen, Latent Membrane Protein-1, and -2A on Systemic Lupus Erythematosus., PMID:29497417
Epstein-Barr virus infection and type I interferon signature in patients with systemic lupus erythematosus., PMID:29338588
The potential of currently unavailable herpes virus vaccines., PMID:29313728
Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar., PMID:29228016
Analysis of Immunogenicity of Intracellular CTAR Fragments of Epstein-Barr Virus Latent Phase Protein LMP1., PMID:29063322
For research use only. Not for human or drug use.
